Drug intelligence / Profile preview

platinum azidothymidine

Development stage
Preclinical
Modality
Small Molecules
Administration
Intraperitoneal
01

Overview

Platinum azidothymidine (Pt-AZT) is a **synthetic platinum-based compound** derived from the antiretroviral drug azidothymidine (AZT) and a platinum moiety. It is designed to combine the anticancer activity of platinum compounds (like cisplatin) with the telomerase-inhibiting property of AZT. Pt-AZT reduces telomerase activity and Bcl-2 expression in cancer cells, which promotes apoptosis and suppresses tumor growth. Preclinical studies in rat models of hepatocellular carcinoma have shown that Pt-AZT is more effective than AZT alone in decreasing both telomerase activity and Bcl-2 concentration, thereby inhibiting cancer progression and metastasis. Its mechanism of action targets cancer cell proliferation through apoptosis induction and telomerase inhibition. This compound has been investigated primarily for anticancer effects, especially in hepatocellular carcinoma[1][3].

Other names
platin-3-azido-2,3-dideoxythymidine
02

Targets

BCL-2 (BCL-2 family)TERT (Telomerase)

Beyond the preview

Go deeper on platinum azidothymidine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on platinum azidothymidine.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call